Compare MMLP & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMLP | APYX |
|---|---|---|
| Founded | 2002 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.5M | 128.0M |
| IPO Year | 2002 | 1995 |
| Metric | MMLP | APYX |
|---|---|---|
| Price | $2.72 | $3.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.00 | ★ $6.50 |
| AVG Volume (30 Days) | 13.4K | ★ 125.9K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | N/A | ★ 19.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,653,009,000.00 | N/A |
| Revenue This Year | N/A | $11.93 |
| Revenue Next Year | N/A | $11.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.65 | N/A |
| 52 Week Low | $2.21 | $0.83 |
| 52 Week High | $3.54 | $4.50 |
| Indicator | MMLP | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 54.66 |
| Support Level | $2.53 | $3.82 |
| Resistance Level | $2.77 | $4.18 |
| Average True Range (ATR) | 0.15 | 0.22 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 51.16 | 58.82 |
Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.